Circulating Maternal Serum Cell Free Fetal DNA Levels for prediction of Preeclampsia

EVALUATION OF MATERNAL SERUM ENDOGLIN IN PREECLAMPSIA AND IN NORMOTENSIVE PREGNANT FEMALES

Maternal serum SHARP1 and hypoxia inducible factor-1α as biomarkers for preeclampsia

Serum endoglin as a second trimester marker for predicting preeclampsia

Pregnancy-Associated Placental Protein A2/Placental Growth Factor Ratio Might Discriminate Normotensive Pregnant Women Who Are Liable to Develop Early-Onset Preeclampsia

Predictive Value of both Serum Placental Protein-13 Level and Uterine Artery Doppler for Prediction of Pre-Eclampsia

First-Trimester Placental Thickness for Prediction Preeclampsia or Small Gestational Age

Maternal serum placental growth factor and Preeclampsia

High Serum Levels of Cardiac Troponin I., Tumor Necrosis Factor-Α and D-Dimer Could be Used as Early Predictors for Upcoming Preeclampsia and its Severity

Value of 3D Ultrasonographic Assessment of Placental Volume and Perfusion Indices in The First Trimester As Predictors to The Occurrence of Preeclampsia